Total Payments
$629.17
2024 Payments
$143.53
Companies
11
Transactions
34
Payment Breakdown by Category
Food & Beverage$629.17 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $629.17 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $117.24 | 7 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $99.79 | 5 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $98.51 | 5 | $0 (2024) |
| Alkermes, Inc. | $64.76 | 3 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $59.80 | 3 | $0 (2022) |
| AbbVie Inc. | $52.53 | 3 | $0 (2021) |
| Shire North American Group Inc | $44.99 | 3 | $0 (2018) |
| IRONSHORE PHARMACEUTICALS INC. | $36.56 | 2 | $0 (2024) |
| ITI, Inc. | $25.44 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $16.48 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.53 | 8 | Teva Pharmaceuticals USA, Inc. ($63.60) |
| 2022 | $70.72 | 3 | ITI, Inc. ($25.44) |
| 2021 | $106.41 | 6 | AbbVie Inc. ($52.53) |
| 2020 | $136.69 | 7 | Sunovion Pharmaceuticals Inc. ($46.03) |
| 2019 | $92.97 | 5 | Alkermes, Inc. ($22.67) |
| 2018 | $13.05 | 1 | Shire North American Group Inc ($13.05) |
| 2017 | $65.80 | 4 | Otsuka America Pharmaceutical, Inc. ($33.86) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Neurology | ||||||
| 11/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/26/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 01/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neurology | ||||||
| 07/13/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Neuropsychiatry | ||||||
| 06/30/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: CNS | ||||||
| 10/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: CNS | ||||||
| 01/15/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: CNS | ||||||
| 09/03/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: CNS | ||||||
| 08/26/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Central Nervous System | ||||||
| 08/12/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Central Nervous System | ||||||
| 08/05/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: CNS | ||||||
| 06/18/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROLOGY | ||||||
| 06/11/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: CNS | ||||||
| 02/26/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: CNS | ||||||
About Dr. Tasneem Ali, MD
Dr. Tasneem Ali, MD is a Child & Adolescent Psychiatry healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1215094685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tasneem Ali, MD has received a total of $629.17 in payments from pharmaceutical and medical device companies, with $143.53 received in 2024. These payments were reported across 34 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($629.17).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Lancaster, PA
- Active Since 01/03/2007
- Last Updated 07/21/2022
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1215094685
Products in Payments
- LATUDA (Drug) $99.79
- REXULTI (Drug) $67.17
- ARISTADA (Drug) $64.76
- UZEDY (Drug) $63.60
- INGREZZA (Drug) $59.80
- VRAYLAR (Drug) $52.53
- VYVANSE (Drug) $44.99
- JORNAY PM (Drug) $36.56
- ABILIFY MAINTENA (Drug) $35.60
- AUSTEDO (Drug) $34.91
- CAPLYTA (Drug) $25.44
- INVEGA SUSTENNA (Drug) $16.48
- ABILIFY ASIMTUFII (Drug) $14.47
- FANAPT (Drug) $13.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Lancaster
Dr. Robert Imani, M.d, M.D
Child & Adolescent Psychiatry — Payments: $11,877
Child & Adolescent Psychiatry $11,877
Santoshkumar Mathapati, M.d, M.D
Child & Adolescent Psychiatry — Payments: $3,104
Child & Adolescent Psychiatry $3,104
Nathaniel Johns, Md, MD
Child & Adolescent Psychiatry — Payments: $2,589
Child & Adolescent Psychiatry $2,589
Dr. Matthew Louie, M.d, M.D
Child & Adolescent Psychiatry — Payments: $1,288
Child & Adolescent Psychiatry $1,288
Olaniyi Oluleye, Md, MD
Child & Adolescent Psychiatry — Payments: $489.62
Child & Adolescent Psychiatry $489.62
Thomas Foley, M.d, M.D
Child & Adolescent Psychiatry — Payments: $407.31
Child & Adolescent Psychiatry $407.31